Drug intelligence / Profile preview

testosterone propionate + testosterone phenylpropionate + testosterone isocaproate + testosterone decanoate

Development stage
Unknown
Lead developer
Alpha-Pharma Healthcare
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Induject, specifically Induject-250, is an injectable oil-based solution containing a blend of four testosterone esters: testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate. Developed and manufactured by Alpha-Pharma Healthcare, this formulation is designed to mimic the pharmacokinetic profile of the well-known Sustanon 250. The combination of short-, medium-, and long-acting esters allows for both a rapid onset of action and a prolonged therapeutic effect, maintaining stable testosterone levels over an extended period. Induject is primarily indicated for testosterone replacement therapy in males with primary or secondary hypogonadism. Its mechanism of action involves the activation of the androgen receptor, which regulates gene expression to promote the development of male sexual characteristics, increase muscle mass, and maintain bone density.

Brand names
IndujectInduject-250Induject250Induject 250
Other names
Testosterone blendTestosterone compoundTestosterone esters
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on testosterone propionate + testosterone phenylpropionate + testosterone isocaproate + testosterone decanoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on testosterone propionate + testosterone phenylpropionate + testosterone isocaproate + testosterone decanoate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call